Publications by authors named "Daphne Ware"

Melioidosis, caused by , is a rare but potentially fatal bacterial disease endemic to tropical and subtropical regions worldwide. It is typically acquired through contact with contaminated soil or fresh water. Before this investigation, was not known to have been isolated from the environment in the continental United States.

View Article and Find Full Text PDF
Article Synopsis
  • Group bacteria with anthrax toxin genes can lead to deadly anthrax pneumonia in welders.
  • Two cases from 2020 were investigated to find the source of exposure, involving environmental sampling of soil and dust at the patients' worksites.
  • The investigation revealed that while one patient's samples showed positive results for anthrax toxins, including matching the patient's clinical isolate, the other patient's samples tested negative, highlighting the importance of workplace assessments to reduce exposure risks.
View Article and Find Full Text PDF

As part of public health preparedness for infectious disease threats, CDC collaborates with other U.S. public health officials to ensure that the Laboratory Response Network (LRN) has diagnostic tools to detect Orthopoxviruses, the genus that includes Variola virus, the causative agent of smallpox.

View Article and Find Full Text PDF

Identification of antigenic variants is the key to a successful influenza vaccination program. The empirical serological methods to determine influenza antigenic properties require viral propagation. Here a novel quantitative PCR-based antigenic characterization method using polyclonal antibody and proximity ligation assays, or so-called polyPLA, was developed and validated.

View Article and Find Full Text PDF

Infections caused by Streptococcus pneumoniae (pneumococcus) are a major cause of mortality throughout the world. This organism is primarily a commensal in the upper respiratory tract of humans, but can cause pneumonia in high-risk persons and disseminate from the lungs by invasion of the bloodstream. Currently, prevention of pneumococcal infections is by immunization with vaccines which contain capsular polysaccharides from the most common serotypes causing invasive disease.

View Article and Find Full Text PDF